Desvenlafaxine NDC 63304-192

NDC codes

FDA NDC Directory

Product NDC (as listed)63304-192Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63304-0192Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63304-192-30	63304019230	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-192-30)Marketed from Mar 5, 2013
63304-192-90	63304019290	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-192-90)Marketed from Mar 5, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Desvenlafaxine
Generic name (nonproprietary): desvenlafaxine
Active ingredients: Desvenlafaxine — 100 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 204150
Marketing start: Mar 5, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 63304-192_cd04a0b2-a7f2-4629-997f-af2a8e65f15bSPL ID cd04a0b2-a7f2-4629-997f-af2a8e65f15bSPL set ID 91cf39c9-4d26-480a-a3a3-a3d8d4c4d222RxCUI 790264, 790288UNII NG99554ANW
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463304019230 followed by a unit qualifier and the quantity

Package 63304-0192-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 7, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14)] . Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) (1).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 204150

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 204150
Product	Strength	Form · route	Labeler	Product NDC
Desvenlafaxine	Desvenlafaxine 50 mg/1	Tablet, Extended releaseOral	Alembic Pharmaceuticals Limited	46708-152
Desvenlafaxine	Desvenlafaxine 100 mg/1	Tablet, Extended releaseOral	Alembic Pharmaceuticals Limited	46708-153
Desvenlafaxine	Desvenlafaxine 50 mg/1	Tablet, Extended releaseOral	Sun Pharmaceutical Industries, Inc.	63304-191